Search Results for "1"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for 1. Results 1861 to 1870 of 2575 total matches.
Quinupristin/Dalfopristin
The Medical Letter on Drugs and Therapeutics • Nov 19, 1999 (Issue 1066)
and -resistant Streptococcus pneumoniae (RG Finch, Drugs, 51 suppl 1:31, 1996). It also is active in vitro ...
Quinupristin and dalfopristin, two streptogramin antibacterials marketed in a 30:70 combination as Synercid, have received accelerated approval from the FDA for intravenous treatment of bacteremia and life-threatening infection....
Fluoxetine Sarafem For Premenstrual Dysphoric Disorder
The Medical Letter on Drugs and Therapeutics • Jan 22, 2001 (Issue 1096)
Halbreich et al and EW Freeman et al, Int J Neuropsychopharmacol July 2000;
3 suppl 1:S248 and S241 ...
Fluoxetine, a selective serotonin reuptake inhibitor (SSRI) previously sold only as Prozac, is now also marketed as Sarafem for treatment of premenstrual dysphoric disorder (PMDD). Generic fluoxetine is expected to be available sometime this year.
A New Snake Antivenom
The Medical Letter on Drugs and Therapeutics • Jun 25, 2001 (Issue 1107)
is available from Savage Laboratories (1-800-2310206). The cost of 12 vials would be $9,300. Although ...
CroFab, an antigen-binding-fragment (Fab) antivenom of ovine origin, has been approved by the FDA for treatment of North American rattlesnake envenomation.
Zoledronate (Zometa)
The Medical Letter on Drugs and Therapeutics • Dec 10, 2001 (Issue 1120)
%) (JP Brown et al, J Bone Miner Res 2001; 16 suppl
1:S218, abstract F353).
ADVERSE EFFECTS — Adverse ...
Zoledronic acid (Zometa), a new bisphosphonate, has been approved by the FDA for intravenous (IV) treatment of hypercalcemia of malignancy.
Pegfilgrastim (Neulasta) For Prevention of Febrile Neutropenia
The Medical Letter on Drugs and Therapeutics • May 13, 2002 (Issue 1130)
al, Blood 2001; 98 (11 part 1):799a, abstract 3322).
No data are available on use of pegfilgrastim ...
Recombinant human granulocyte colony stimulating factor (G-CSF, filgrastim) conjugated to polyethylene glycol (pegfilgrastim, Neulasta - Amgen) has been approved by the FDA for use in neutropenic patients with non-myeloid malignancies who are at high risk for infection. Filgrastim (Neupogen - Amgen) has been available in the US since 1991.
Anastrozole (Arimidex) vs. Tamoxifen for Treatment of Early Breast Cancer
The Medical Letter on Drugs and Therapeutics • Mar 17, 2003 (Issue 1152)
in postmenopausal women. It suppresses serum
estrogen to 1%-10% of pre-treatment levels.
PHARMACOKINETICS ...
Anastrozole (Arimidex - AstraZeneca, Medical Letter 1996; 38:61), an aromatase inhibitor, has received accelerated approval from the FDA for adjuvant treatment of postmenopausal women with early hormone-receptor-positive breast cancer. The drug was approved for treatment of postmenopausal women with metastatic breast cancer in 1996.
Zingo for Local Analgesia in Children
The Medical Letter on Drugs and Therapeutics • Aug 25, 2008 (Issue 1293)
Publication
1. WT Zempsky et al. A novel needle-free powder lidocaine delivery system for rapid local ...
The FDA has approved the marketing of a new device for delivering lidocaine to the skin of children undergoing a venipuncture or intravenous (IV) line placement. Zingo (Anesiva) is a powder intradermal injection system.
In Brief: New Propellants for Albuterol Metered-Dose Inhalers
The Medical Letter on Drugs and Therapeutics • Nov 03, 2008 (Issue 1298)
Publication
New Propellants for Albuterol Metered-Dose
Inhalers
IN BRIEF
Drug Dosage
1
Cost
2 ...
Inhaled drugs for asthma are available in the US mainly in pressurized metered-dose inhalers (MDIs), which require a propellant, and dry powder inhalers, which do not. The chlorofluorocarbon (CFC) propellants in MDIs are being replaced by hydrofluoroalkane (HFA) propellants for environmental reasons: CFCs contribute to the depletion of the ozone layer. December 31, 2008 will be the last day that albuterol MDIs using CFC propellants can be sold in the US. The FDA is expected to announce a termination date for other CFC-containing products in the near future.Three HFA albuterol inhalers and one...
Vaccines and Pregnancy
The Medical Letter on Drugs and Therapeutics • Nov 28, 2011 (Issue 1378)
Guidelines from The
Medical Letter.1
BEFORE PREGNANCY — Inactivated vaccines can
be given at any time ...
Live-attenuated vaccines are generally contraindicated
during pregnancy; inactivated vaccines can be
given if indicated. A more detailed review of routine
immunizations for adults will be available in the
December issue of Treatment Guidelines from The
Medical Letter.
Epidural Corticosteroid Injections for Lumbar and Cervical Radiculopathy
The Medical Letter on Drugs and Therapeutics • Jan 23, 2012 (Issue 1382)
and Cervical Radiculopathy
For patients with radicular pain unresponsive to conservative
treatment after 1-2 ...
For patients with radicular pain unresponsive to conservative
treatment after 1-2 months and no progressive
neurologic deficit, epidural corticosteroid
injections are often tried before surgical intervention.